MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.urolonc.2022.06.009

Медицинская библиотека · Urologic oncology · 2022

Impact of the primary tumor location on secondary sites and overall mortality in patients with metastatic upper tract urothelial carcinoma.

Collà Ruvolo Claudia, Deuker Marina, Wenzel Mike, Nocera Luigi, Würnschimmel Christoph, Califano Gianluigi, Tian Zhe, Saad Fred, Briganti Alberto, Xylinas Evanguelos, Verze Paolo, Musi Gennaro, Shariat Shahrokh F, Mirone Vincenzo, Karakiewicz Pierre I

СтатьяПеревод в очереди

Аннотация

BACKGROUND

To date it is unknown whether renal vs. ureteral urothelial carcinoma affects the type and the distribution of metastatic sites, and whether survival differs according to renal vs. ureteral location in metastatic patients.

METHODS

Two datasets were used, namely Surveillance, Epidemiology and End Results (SEER) and National Inpatients Sample (NIS). Multivariable logistic regression models tested whether renal pelvis vs. ureteral location predicts site-specific metastases. Kaplan-Meier plots and multivariable Cox regression models (CRMs) tested overall mortality (OM) according to renal pelvis vs. ureteral location.

RESULTS

In SEER (2010-2016), 623 (71.1%) metastatic renal pelvis urothelial carcinoma (RPUC) vs. 253 (28.9%) ureteral urothelial carcinoma (UUC) patients were identified. Patients with RPUC more frequently harbored lung (46.1% vs. 35.2%, P < 0.01; Odds ratio [OR]: 1.57, P < 0.01), but less frequently liver metastases (27.9% vs. 36.4%, P = 0.02; OR:0.66, P = 0.01). In RPUC, lung, liver, bone, and brain metastases independently predicted higher OM. Only liver metastases independently predicted higher OM in UUC. In NIS (2005-2015), 818 (61.0%) RPUC vs. 522 (39.0%) UUC patients were identified. Patients with RPUC more frequently harbored lung (34.0% vs. 17.2%, P < 0.001; OR:2.36, P < 0.001), as well as brain (4.4% vs. 1.9%, P = 0.02; OR:2.00, P = 0.049) metastases, but less frequently harbored retroperitoneal and/or peritoneal (12.3% vs. 21.8%, P < 0.001; OR:0.51, P < 0.001), urinary tract (9.3% vs. 14.0%, P = 0.01; OR:0.65, P = 0.01) and multiple metastatic sites (62.6% vs. 70.7%, P < 0.01; OR:0.69, P < 0.01).

CONCLUSIONS

In both databases lung metastases were more frequent in RPUC and abdominal metastases were more frequent in UUC. Moreover, liver metastases independently predicted worse survival, regardless of primary site.

Для цитирования: Collà Ruvolo Claudia, Deuker Marina, Wenzel Mike, Nocera Luigi, Würnschimmel Christoph, Califano Gianluigi, Tian Zhe, Saad Fred, Briganti Alberto, Xylinas Evanguelos, Verze Paolo, Musi Gennaro, Shariat Shahrokh F, Mirone Vincenzo, Karakiewicz Pierre I. Impact of the primary tumor location on secondary sites and overall mortality in patients with metastatic upper tract urothelial carcinoma.. Urologic oncology. 2022. DOI: 10.1016/j.urolonc.2022.06.009.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.